Share this article
Share this article
CAMBRIDGE, Mass., Jan. 13, 2021 /PRNewswire/ LabCentral, the first-of-its-kind shared laboratory space designed as a launchpad for high-potential biotech startups, today announced LabCentral Ignite, a new initiative with the goal of enhancing regional biotech innovation by stimulating a robust pipeline of diverse, qualified talent. Through internal programming and grants to non-profits focused on STEM education, workforce training and entrepreneurial development, LabCentral Ignite will facilitate broader access to the biotech industry, with emphasis on socio-economically disadvantaged, underserved and under-represented individuals and communities.
To oversee the program s growth and development, LabCentral has promoted Krista Licata to the role of managing director of LabCentral Ignite. She has spent the past seven years with LabCentral in a variety of roles, most recently serving as the senior director of site operations.
Listen
Rapid testing could be the key back to life as we once knew it. So what s the hold up?
The Case For Rapid Tests
Rapid tests like the ones from LabCentral are simple and can be taken and read from home in minutes.
Sarah Leeson
Share Listen 32:46
Rapid testing could be the key back to life as we once knew it. So what s the hold up?
Imagine a world where you could walk into any corner store, find a COVID-19 rapid test, buy it for just a few dollars, and know within minutes whether you are, or are not, contagious with coronavirus. You wouldnât need a doctorâs referral to buy one. You wouldnât need a lab technician to read the result. You wouldnât even need to endure the deep (and often painful) sinus swab to get the sample.